|
See related Ferriprox information |
|
|
|
Manufacturer |
Apotex |
|
Distributor |
Biogenetech |
|
Contents |
Deferiprone |
|
Indications |
Treatment of Fe overload in patients w/ thalassemia major when deferoxamine therapy is contraindicated or inadequate. |
|
Dosage |
Tab 25 mg/kg body wt tid. Oral soln 75 mg/kg/day. |
|
Administration |
May be taken with or without food (Take after meals.). |
|
Contraindications |
History of repeated neutropenia, agranulocytosis. Pregnancy & lactation. |
|
Special Precautions |
Monitor any sign of infection eg fever, sore throat or flu-like symptoms. Monitor serum ALT level & body Fe load regularly. HIV +ve or other immunocompromised patients. Neurological disorder in childn in long-term overdose. |
|
Adverse Drug Reactions |
Neutropenia or agranulocytosis. Joint pain & swelling. Increased hepatic enzymes, abdominal pain, nausea, vomiting, diarrhea & increased appetite.
View ADR Monitoring Form |
|
Drug Interactions |
Drugs associated w/ neutropenia or agranulocytosis. Trivalent cations eg Al-based antacids. Vit C.
View more drug interactions with Ferriprox |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Ferriprox film-coated tablet |
|
Ferriprox 500 mg x 100's |
 |
|
|
Ferriprox oral solution |
|
Ferriprox 100 mg/1 mL x 500 mL |
 |
|
|
|
Manufacturer: |
Apotex |
|
Distributor: |
Biogenetech
|
|
|
|
